Alex is a medicinal chemist passionate about drug discovery! Over almost two decades in the industry, he has contributed to more than a dozen development candidates, two of which have reached registration trials in the clinic. Before joining Inductive Bio, Alex was VP, Head of Chemistry at Relay Therapeutics, where the team integrated traditional medicinal chemistry approaches with predictive ADME and potency models into the identification of development candidates. He has worked across multiple small molecule classes and mechanisms of action, including reversible, covalent, chaperone, degrader, and macrocyclic peptides. Alex got his start in industry at Constellation Pharmaceuticals, applying fragment based drug design to the creation of selective bromodomain inhibitors, in collaboration with Genentech.

Before becoming a medicinal chemist, Alex completed his Ph.D. studies at Harvard University with Stuart Schreiber and was a postdoctoral fellow at MIT in the lab of Steve Buchwald. He did undergraduate research at Vanderbilt University with Ned Porter and was a Fulbright Scholar at the Universität Basel with Bernd Giese. Outside of work, Alex loves running along the Charles River and cheering for the Celtics with his family.